Loading...

Biotin anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_Biotin_042706
C57BL/6 mouse bone marrow cells were stained with biotinylated CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by Sav-PE (gated on total cells).
  • M1slash70_Biotin_042706
    C57BL/6 mouse bone marrow cells were stained with biotinylated CD11b (clone M1/70) (filled histogram) or rat IgG2b, κ isotype control (open histogram), followed by Sav-PE (gated on total cells).
Compare all formats
Cat # Size Price Quantity Check Availability Save
101203 50 µg 34€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101204 500 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Ochiai S, et al. 2014. J Immunol. 193:2504. PubMed
  2. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  3. Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
  4. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  5. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  6. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  7. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  8. Elsner R, et al. 2015. PLoS Pathog. 10: 1004976. PubMed
  9. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  10. Thierry GR, et al. 2018. J Exp Med. 215:2972. PubMed
  11. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  12. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  13. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  14. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  15. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  16. Guo F, et al. 2022. Front Immunol. 13:833100. PubMed
  17. Zhou L, et al. 2021. Cell Mol Immunol. 18:698. PubMed
  18. Wang Y, et al. 2022. Front Immunol. 12:809896. PubMed
  19. Yokozeki Y, et al. 2021. BMC Musculoskelet Disord. 22:634. PubMed
  20. Chou H, et al. 2011. Hepatology. 53:1007. PubMed
  21. Matson CA, et al. 2020. Proc Natl Acad Sci U S A. 117:14342. PubMed
  22. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  23. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  24. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  25. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  26. Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed
  27. Sasse C, et al. 2022. Pathogens. 11:. PubMed
  28. Matsumoto R, et al. 2021. Front Pharmacol. 12:715752. PubMed
  29. Browning LM, et al. 2020. Cell Rep. 33:108219. PubMed
  30. Chen J et al. 2018. Cell reports. 25(12):3393-3404 . PubMed
  31. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  32. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  33. Periasamy S, et al. 2016. PLoS Pathog. 12: 1005517. PubMed
  34. Van de Velde L, et al. 2016. Cell Rep. 17:2247-2258. PubMed
  35. Xu X, et al. 2020. J Cell Biol. 219:00:00. PubMed
  36. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  37. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  38. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  39. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  40. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  41. Bian Y, et al. 2017. PLoS Pathog. 13:e1006384. PubMed
  42. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  43. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  44. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  45. Ben C, et al. 2020. J Biol Chem. 295:13965. PubMed
  46. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  47. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  48. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  49. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  50. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  51. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  52. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  53. Ramos CV, et al. 2020. Cell Reports. 32(3):107910. PubMed
  54. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  55. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  56. Köchl R, et al. 2020. Elife. 9:00. PubMed
  57. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  58. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  59. Onodera T, et al. 2019. J Immunol. 203:3282. PubMed
  60. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  61. Lopez DA, et al. 2022. Cell Rep. 41:111677. PubMed
  62. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  63. Noah AC, et al. 2020. J Appl Physiol (1985). 473:128. PubMed
  64. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  65. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  66. Vural A, et al. 2019. J Immunol. 202:1510. PubMed
  67. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  68. Carr M, et al. 2016. Proc Natl Acad Sci U S A. 113(52):15024-15029. PubMed
  69. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  70. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  71. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  72. Lin C, et al. 2022. Nat Commun. 13:6869. PubMed
  73. Onodera T, et al. 2021. Immunity. 54:2385. PubMed
  74. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  75. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  76. Sasaki T, et al. 2020. Cell Reports. 28(1):202-217.e7.. PubMed
  77. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  78. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  79. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  80. Au-Yeung BB, et al. 2017. J Immunol. 198:2445. PubMed
  81. Leyva‐Castillo JM et al. 2019. Immunity. 50(5):1262-1275 . PubMed
  82. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  83. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  84. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  85. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  86. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  87. Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
  88. Akkaya B, et al. 2017. J Immunol Methods. 441:67. PubMed
  89. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  90. Liu G, et al. 2022. Ann Transl Med. 10:693. PubMed
  91. Tsuzuki S, et al. 2015. Int Immunol. 10.1093/intimm/dxv058. PubMed
  92. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  93. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  94. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  95. Stofkova A, et al. 2021. Int J Mol Sci. 23:. PubMed
  96. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  97. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  98. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  99. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  100. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  101. Oliveira AC et al. 2017. eLife. 6 pii: e30883. PubMed
  102. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  103. Chen Z, et al. 2020. Cell Death Dis. 11:180. PubMed
  104. Scortegagna M, et al. 2020. Nat Commun. 11:99. PubMed
  105. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  106. Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
  107. Wang Y, et al. 2022. Front Immunol. 13:847581. PubMed
  108. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  109. Rohrbeck L, et al. 2020. Immunol Cell Biol. . PubMed
  110. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  111. De Micheli AJ, et al. 2020. Cell Rep. 30:3583. PubMed
  112. Stofkova A, et al. 2019. Sci Rep. 2.009027778. PubMed
  113. Murata T, et al. 2020. Sci Rep. 10:13560. PubMed
  114. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  115. Koide S, et al. 2022. iScience. 25:103603. PubMed
  116. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  117. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  118. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  119. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  120. Ma C, et al. 2021. J Exp Med. :218. PubMed
  121. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  122. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  123. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  124. Yrlid U, et al. 2019. J Leukoc Biol. 105:195. PubMed
  125. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  126. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  127. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  128. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  129. Teng Y, et al. 2021. Mol Ther. 29:2424. PubMed
  130. Young K, et al. 2021. Cell Stem Cell. . PubMed
  131. Frohlich J, et al. 2020. Aging (Albany NY). 12:20024. PubMed
  132. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
  133. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
RRID
AB_312786 (BioLegend Cat. No. 101203)
AB_312787 (BioLegend Cat. No. 101204)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS UV™ 395 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account